Cipla, a leading Indian pharmaceutical company, has been honored with a customized stamp released by India Post to commemorate its 90th anniversary. The ₹5 stamp features the image of Dr. YK Hamied, a doyen of Cipla, with the company’s recent Mumbai office as the backdrop. The release of the stamp was attended by Dr. Hamied, his brother MK Hamied, and other Cipla employees, and was also live-streamed to the company’s global offices and sites.
The stamp was released by Suchita Joshi, Postmaster General of Navi Mumbai, in September, although the company had actually turned 90 in August. This milestone is a significant achievement for Cipla, which has established itself as one of the leading generic pharmaceutical companies in India and across the world. The company has a strong presence in Africa, the USA, Europe, and other selected markets.
Dr. Hamied had earlier stated that Cipla would continue to provide accessible and quality products to India and the world. He also outlined the company’s future focus areas, including respiratory, cardiac, cancer, obesity, and mental health segments, as well as anti-microbials. This is not the first time a pharmaceutical company has been honored with a customized stamp in India. Earlier this year, GlaxoSmithKline (GSK) had a stamp released to mark its 100 years in the country.
The release of the customized stamp is a testament to Cipla’s contributions to the pharmaceutical industry and its commitment to providing quality products to patients worldwide. As the company looks to the future, it is likely to continue playing a significant role in shaping the global healthcare landscape. With its strong presence in various markets and its focus on critical therapeutic areas, Cipla is well-positioned to address the evolving healthcare needs of patients around the world. The company’s 90th anniversary is a significant milestone, and the customized stamp is a fitting tribute to its achievements.